Glp-1 and exendin related invention

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/605 (2006.01) A61K 38/16 (2006.01) C07K 14/575 (2006.01)

Patent

CA 2578252

The invention relates to peptides derived from GLP-1 (Glucagon-like Peptide 1) and exendin-3 and/or exendin-4, which bind to GLP-1 receptors and may be used either marked or unmarked for the production of a means for diagnosis and therapy of benign and pernicious diseases in which GLP-1 receptor expression plays a role.

Selon la présente invention, des peptides dérivés du GLP-1 (glucagon-like peptide-1) et de l'exendine-3 et/ou exendine-4 sont préparés, lesquels peptides se lient au récepteur du GLP-1 et sont utilisés, marqués ou non marqués, dans la production d'un agent servant au diagnostic et à la thérapie de maladies bénignes et malignes, dans lesquelles l'expression du récepteur du GLP-1 joue un certain rôle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glp-1 and exendin related invention does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glp-1 and exendin related invention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 and exendin related invention will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2046925

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.